Trastornos del movimiento (IV)otros trastornos del movimiento

  1. Alonso-Navarro, H.
  2. Jiménez-Jiménez, F.J.
  3. Luquin Piudo, M.R.
  4. Burguera Hernández, J.A.
Zeitschrift:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Datum der Publikation: 2015

Serie: 11

Nummer: 74

Seiten: 4454-4465

Art: Artikel

DOI: 10.1016/J.MED.2015.02.013 DIALNET GOOGLE SCHOLAR

Andere Publikationen in: Medicine: Programa de Formación Médica Continuada Acreditado

Zusammenfassung

We describe the clinical characteristics and semiological, diagnostic and therapeutic aspects of other movement disorders, including familial essential tremor (the most common movement disorder), myoclonic syndromes, hemifacial spasms and tics, restless leg syndromes, “painful legs and moving toes” syndrome, startle syndrome and stiff-person syndrome.

Bibliographische Referenzen

  • Lou JS, Jankovic J. Essential tremor: clinical correlates in 350 patients. Neurology. 1991;41:234-8.
  • Koller WC, Busenbark K, Miner K, and the Essential Tremor Study Group. The relationship of essential tremor to other movement disor-ders: report on 678 patients. Ann Neurol. 1994;35:717-23.
  • Tallón-Barranco A, Vázquez A, Jiménez-Jiménez FJ, Ortí-Pareja M, Ga-salla T, Cabrera-Valdivia F, et al. Clinical features of essential tremor seen in Neurology practice: a study of 357 patients. Parkinsonism Relat Di-sord. 1998;4:187-90.
  • Jiménez-Jiménez FJ, Cabrera-Valdivia F, Ortí-Pareja M, Gasalla T, Ta-llón-Barranco A, Zurdo M. Bilateral primary writing tremor. Eur J Neu-rol. 1998;5:613-4.
  • Deuschl G, Bain P, Brin M. Consensus statement of the Movement Di-sorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord. 1998;13Suppl3: 2-23.
  • Louis ED. Essential tremor. Lancet Neurol. 2005;4:100-10.
  • Alonso-Navarro H, Rubio Ll, Benito-León J, Vázquez Rodríguez A, Ji-ménez-Jiménez FJ. Temblor esencial. En: Jiménez-Jiménez FJ, Luquin MR, Molina JA, Linazasoro G, editors. Tratado de los trastornos del mo-vimiento. 2ª ed. Vol. 2. Cap. 33. Barcelona: Viguera Editores S.L.; 2008. p. 829-82.
  • Jiménez-Jiménez FJ, Rubio L, Alonso-Navarro H, Calleja M, Benito-León J, Plaza-Nieto JF, et al. Impairment of rapid repetitive finger move-ments and visual reaction time in essential tremor. Eur J Neurol. 2010;17:152-9.
  • Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JAG. The relationship between Parkinson’s disease and essential tremor: re-view of clinical, epidemiologic, genetic, neuroimaging and neuropatholo-gical data, and data on the presence of cardinal signs of parkinsonism in essential tremor. Tremor Other Hyperkynet Mov. 2012; 2: Dispinible en: http://tremorjournal.org/article/view/75.
  • Jiménez-Jiménez FJ, Alonso-Navarro H, Garcia-Martin E, Lorenzo-Be-tancor O, Pastor P, Agúndez JAG. Update on genetics of essential tremor. Acta Neurol Scand. 2013;128:359-71.
  • Alonso-Navarro H, Jiménez-Jiménez FJ, García-Martín E, Agúndez JAG. Neurochemistry and Neuropharmacology of Essen-tial Tremor. En: Rhaman AU, editor (e-book). Frontiers in clinical drug research - CNS and neurological disorders (Vol. 2). Bentham Science Publishers; 2013. p. 110-42.
  • Fahn S, Marsden CD, Van Woert MH. Definition and classification of myoclonus. Adv Neurol. 1986;43:1-5.
  • Obeso JA, Artieda J, Marsden CD. Different clinical presentations of myoclonus. En: Jankovic J, Tolosa E, editors. Parkinson’s disease and mo-vement disorders. 2nd ed. Baltimore: Williams & Wilkins, 1993. p. 315-28.
  • Obeso JA. Classification, clinical features, and treatment of myoclonus. En: Watts RL, Koller WC, editors. Movement disorders. New York: McGraw-Hill; 1997. p. 541-50.
  • Jiménez-Jiménez FJ, García-Ruiz PJ, Molina JA. Drug-induced move-ment disorders. Drug Safety. 1997;16:180-204
  • Giménez-Roldán S. Farmacología y tratamiento de las mioclonías. En: Jiménez-Jiménez FJ, Luquin MR, editores. Neuroquímica y neurofarma-cología de los trastornos del movimiento. Neurología 2003;18Supl3:72-9.
  • Jiménez-Jiménez FJ, Puertas I, de Toledo-Heras M. Drug-indu-ced myoclonus: frequency, mechanisms and management. CNS Drugs. 2004;18:93-104.
  • Blindauer K. Mioclonía. Continuum: American Academy of Neurology. Trastornos del movimiento. Barcelona: Medical Trends; 2005. p. 133-44.
  • Shannon KM. Trastornos del movimiento. En: Bradley WG, Daroff RB, Fenichel GM, Jankovic J, editores. Neurología Clínica. Madrid: Elsevier España. 2005. p. 2105-52.
  • Salas-Puig X, Ribacoba R. Síndromes mioclónicos. En: Jiménez-Jiménez FJ, Luquin MR, Molina JA, Linazasoro G, editores. Tratado de los trastornos del movimiento. 2ª ed. Vol. 3. Cap. 44. Barcelona: Viguera Editores S.L., 2008. p. 1139-66.
  • Weiner WJ, Lang AE. Movement disorders: a comprehensive survey. New Yord: Futura Publishing Company, Inc.; 1989.
  • Tan N, Chan LL, Tan EK. Hemifacial spasm and involuntary facial mo-vements. QJM. 2002;95:493-500.
  • Robertson MM. The Gilles de la Tourette syndrome: the current status. Br J Psychiatry. 1989;154:147-69.
  • Singer HS, Walkup JT. Tourette syndrome and other tic disorders. Diag-nosis, pathophysiology, and treatment. Medicine (Baltimore). 1991;70:15-32.
  • The Tourette Syndrome Classificacion Study Group. Definitions and classification on tic disorders. Arch Neurol. 1993;50:1013-6.
  • Lees AJ, Tolosa E. Tics. En: Jankovic J, Tolosa E, editors. Parkinson’s di-sease and movement disorders. 2nd ed. Baltimore: Williams & Wilkins; 1993. p. 329-35.
  • Suchowerski O. Gilles de la Tourette syndrome. Can J Neurol Sci. 1994;21:48-52.
  • Juncos JL, Freeman A. Pathophysiology and differential diagnosis of tics. En: Watts RL, Koller WC, eds. Movement disorders. New York: Mc-Graw-Hill; 1997. p. 561-8.
  • Jiménez-Jiménez FJ, García-Ruiz PJ. Pharmacological options for the treatment of Tourette’s disorder. Drugs. 2001;61:2207-20.
  • Jiménez-Jiménez FJ, Alonso-Navarro H, Plaza-Nieto JF, Pilo de la Fuen-te B. Síndrome de Tourette. Tratado de los trastornos del movimiento. 2ª ed. Vol 3. Cap. 45. Barcelona: Viguera Editores S.L.; 2008. p. 1167-236.
  • Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Mont-plaisir J, et al. Restless legs syndrome: diagnostic criteria, special conside-rations, and epidemiology. A report from the restless legs syndrome diag-nosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4:101-19.
  • Chaidhuri KR, Forbes A, Grosset D, Lees A, Shneerson J, Scha-pira A, et al. Diagnosing restless legs syndrome (RLS) in primary care. Curr Med Res Opin. 2004;20:1785-95.
  • García-Borreguero D, Larrosa O, Granizo JJ, de la Llave Y, He-ning WA. Circadian variation in neuroendocrine response to L-dopa in patients with restless legs syndrome. Sleep. 2004;27:669-73.
  • Trenkwalder C, Paulus W, Walters AS. The restless legs syndrome. Lan-cet. Neurol 2005;4:465-75.
  • Högl B, Poewe W. Restless legs syndrome. Curr Opin Neurol. 2005;18:405-10.
  • Egatz R, Miranda M, Calvo E, García-Borreguero D. Trastornos del mo-vimiento durante el sueño. En: Jiménez-Jiménez FJ, Luquin MR, Molina JA, Linazasoro G, editores. Tratado de los trastornos del movimiento. 2ª ed. Barcelona: Viguera Editores S.L.; 2008. p. 1433-54.
  • Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JAG. Latest perspectives in genetic risk factors for restless legs syndrome. Eur Neurol Rev. 2013;8:90-6.
  • Allen RP, Picchietti DL, García-Borreguero D, Ondo WG, Walters AS, Winkelmann JW, et al, International Restless Legs Syn-drome Study Group. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated international restless legs syndrome study group (IRLSSG) consensus criteria—history, rationale, des-cription, and significance. Sleep Med. 2014;15:860-73.
  • Dressler D, Thompson PD, Gledhill RF, Marsden CD. The syndrome of painful legs and moving toes. Mov Disord. 1994;9: 13-21.
  • Lang AE. Akathisia and the restless legs syndrome. En: Jankovic J, Tolosa E, editors. Parkinson’s disease and movement disorders. 2nd ed. Baltimore: Williams & Wilkins; 1993. p. 399-418.
  • Giménez-Roldán S, Hípola D. El reflejo de sobresalto en el hombre y su patología: un ensayo de clasificación. Neurología. 1994;9:148-57.
  • Aguirre-Sánchez JJ. Síndrome de persona rígida. En: Jiménez-Jiménez FJ, Luquin MR, Molina JA, Linazasoro G, editores. Tratado de los trastornos del movimiento. 2ª ed. Vol. 3. Cap. 48. Barcelona: Viguera Editores S.L.; 2008. p. 1283-92.
Fuente de los datos: Dialnet